Skyrizi 60 mg

SKYRIZI 60 MG is a solution for intravenous use, containing risankizumab. This medication is designed to support immune system modulation, often used for specific inflammatory conditions.

SKYRIZI 60 MG is primarily used for managing moderate to severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy. Risankizumab works by targeting specific proteins in the immune system to reduce inflammation. This medication is often prescribed when other treatments have not been effective or are not suitable.

Common effects of SKYRIZI 60 MG may include reactions at the injection site, such as redness or itching. Some users might experience fatigue, headache, or upper respiratory infections. These effects vary and are not experienced by everyone.

SKYRIZI 60 MG should be used under medical supervision. It is important to inform your healthcare provider about any allergies or existing medical conditions before starting this treatment. Regular monitoring may be required to ensure the medication is working as intended.

SKYRIZI 60 MG may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect how this medication works.